NRG4 expression is reduced in adipose tissue from obese mice, and lower plasma NRG4 levels are associated with obesity, insulin resistance, and NAFLD in humans (22–24). Here, NRG4 is linked to obesity due to melanocortin 4 receptor deficiency.